Trial of Volasertib With or Without Azacitidine in Patients With Myelodysplastic Syndromes

NCT02721875 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Conditions

Myelodysplastic Syndromes

Interventions

DRUG: Volasertib
DRUG: Volasertib
DRUG: Azacitidine

Sponsor

Boehringer Ingelheim